CHRNA4 and COVID-19: In this scenario, nicotine inhibits the respective receptor (nAChR) explaining the low frequencies of smokers in the COVID-19 cohorts and suspecting nicotine or other pharmaceutical nicotine products as therapeutic agents to target COVID-19 (Farsalinos et al., 2020b; Kloc et al., 2020).